$DOCU

Yorkville Ives initiated coverage on Docusign (DOCU) with an In Line rating and a $72 price target, citing AI risks and growth potential. The stock has gained 44% over six months. Analysts highlight Docusign's strong financials, including an 80% gross margin, and recent product releases. Several firms raised their price targets following the company's 9.4% revenue growth in Q2, driven by digital sales and IAM bookings.

Docusign (DOCU) Chief Revenue Officer Paula Hansen sold 3,300 shares on 2026-10-01, retaining 106,557 shares. This follows a trend of 41 insider sells and 0 buys in the past year. The stock trades at $68.81, with a P/E of 41.98, and is considered fairly valued by GuruFocus. Institutional investors are divided, with 3 adding and 5 trimming positions.

DocuSign CRO Paula Hansen sold 3,300 shares of DOCU stock on October 1, 2026, totaling $227,061. The sales were part of a 10b5-1 plan. DOCU shares have risen 43% in six months, trading near a 52-week high. Analysts have mixed price targets, with some seeing undervaluation and others focusing on IAM growth. The company reported strong Q2 revenue growth and raised fiscal 2027 targets.

DocuSign's CLO, James P. Shaughnessy, sold 12,000 shares (total $825,552) on Oct 1, 2026, per a 10b5-1 plan. Shares sold at $68.77 and $69.55. He now owns 50,591 shares. DOCU shares are up 43% in 6 months, trading at $69.01. Analysts raised price targets to $72 (Citi, Baird) and $75 (Morgan Stanley), with Wells Fargo at $60. Q2 revenue grew 9.4%.

DocuSign CEO Allan C. Thygesen sold 26,250 shares, totaling $1.82M, via a 10b5-1 plan. He now holds 166,801 shares. DOCU stock is up 43% in 6 months, with a $13B market cap. Analysts raised price targets to $72 (Citi, Baird), $75 (Morgan Stanley), and $60 (Wells Fargo) after Q2 revenue growth of 9.4%.

Shaughnessy James P (Chief Legal Officer) sold 12,000 shares of DOCUSIGN, INC. (DOCU) at an average of $68.80 ($68.77–$69.55, $0.83M total) across 2 trades on 2026-10-01 under a Rule 10b5-1 trading plan.

Thygesen Allan C. (President and CEO) sold 26,250 shares of DOCUSIGN, INC. (DOCU) at an average of $69.29 ($68.53–$69.98, $1.82M total) across 3 trades on 2026-10-01 under a Rule 10b5-1 trading plan.

DocuSign's fair value estimate increased by 16% to $70 due to stronger Q2 execution, raised long-term ARR growth targets, and improved margins. Analysts remain neutral, seeking sustained growth in Intelligent Agreement Management (IAM). Bullish analysts cite Q2 beats and IAM traction, while bearish ones highlight incremental IAM progress and demand for double-digit growth. DocuSign was removed from the FTSE All-World Index, reported share buybacks, and raised FY27 revenue guidance.

Chatwani Robert (President General Mgr, Growth) sold 14,676 shares of DOCUSIGN, INC. (DOCU) at an average of $69.41 ($68.77–$69.66, $1.02M total) across 2 trades on 2026-09-17 under a Rule 10b5-1 trading plan.

Docusign reduced AI processing costs by 90% and increased throughput by up to 8x by switching to smaller, specialized models for contract processing, according to Microsoft. The company's AI engine, Iris, extracts key facts from over 1 million contracts daily. Docusign also introduced AI agents in May, which rely on the cost-effective extraction models.